探究omega-3补充对1型糖尿病青少年内皮功能、血管结构和代谢参数影响的随机对照临床试验研究方案
本研究为随机对照临床试验,将60名1型糖尿病青少年随机分为omega-3组(600 mg/天)或安慰剂组,干预12周。评估人体测量参数、血流介导舒张(FMD)、颈动脉内膜中层厚度(CIMT)、蛋白尿、血糖血脂、血尿素氮、肌酐、高敏C反应蛋白、红细胞沉降率及血压,并评估膳食摄入和体力活动。假设omega-3补充可能通过减轻炎症和氧化应激等机制对1型糖尿病管理有益。
要点
- 60名1型糖尿病青少年随机接受omega-3(600 mg/天)或安慰剂12周。
- 主要评估内皮功能(FMD)、血管结构(CIMT)及代谢指标。
- 假设omega-3补充可能通过抗炎、抗氧化等机制对1型糖尿病有益。
核心结论
- 假设omega-3补充可能通过减少炎症和氧化应激、调节免疫反应及糖脂代谢等机制,对1型糖尿病及其并发症的管理有益。
研究设计与样本
- 随机对照临床试验,纳入60名1型糖尿病青少年,随机分为omega-3组(600 mg/天)或安慰剂组,干预12周。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Type 1 diabetes is a main health burden with several related comorbidities. It has been shown that endothelial function, vascular structure, and metabolic parameters are considerably disrupted in patients with type 1 diabetes. Omega-3 as an adjuvant therapy may exert profitable effects on type 1 diabetes and its complications by improving inflammation, oxidative stress, immune responses, and metabolic status. Because no randomized clinical trial has examined the effects of omega-3 consumption in children and adolescents with type 1 diabetes; the present study aims to close this gap. METHODS: This investigation is a randomized clinical trial, in which sixty adolescents with type 1 diabetes will be randomly assigned to receive either omega-3 (600 mg/day) or placebo capsules for 12 weeks. Evaluation of anthropometric parameters, flow-mediated dilation (FMD) as an endothelial function marker, carotid intima-media thickness (CIMT) as a vascular structure marker, proteinuria, biochemical factors including glycemic and lipid profile, blood urea nitrogen (BUN), creatinine, high-sensitivity C-reactive protein (hs-CRP), and erythrocyte sedimentation rate (ESR), as well as blood pressure will be done at the baseline and end of the trial. Also, dietary intake and physical activity will be assessed throughout the study. Statistical analysis will be performed using the SPSS software (Version 24), and P < 0.05 will be considered statistically meaningful. DISCUSSION: It is hypothesized that omega-3 supplementation may be beneficial for the management of type 1 diabetes and its complications by reducing inflammation and oxidative stress and also modulating immune responses and glucose and lipid metabolism through various mechanisms. The present study aims to investigate any effect of omega-3 on patients with type 1 diabetes. ETHICAL ASPECTS: This trial received approval from Medical Ethics Committee of Iran University of Medical Sciences, Tehran, Iran (IR.IUMS.REC.1400.070). TRIAL REGISTRATION: Iranian Registry of Clinical Trials IRCT20210419051010N1 . Registered on 29 April 2021.
引用
- Khorshidi M, Sayyari A, Olang B, et al. Study protocol of a randomized controlled clinical trial investigating the effects of omega-3 supplementation on endothelial function, vascular structure, and metabolic parameters in adolescents with type 1 diabetes. Trials. 2021. PMID: 34961564. doi:10.1186/s13063-021-05930-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。